Clinical Trial Detail

NCT ID NCT03694002
Title Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Southwest Oncology Group
Indications

thymic carcinoma

Therapies

Carboplatin + Paclitaxel

Carboplatin + Paclitaxel + Ramucirumab

Age Groups: adult senior

No variant requirements are available.